Subscribe: Lymphoma / Leukemia / Myeloma News From Medical News Today
http://www.medicalnewstoday.com/rss/lymphoma-leukemia.xml
Added By: Feedage Forager Feedage Grade A rated
Language: English
Tags:
acute  cancer  cells  hodgkin lymphoma  leukaemia  leukemia  lymphoma  multiple myeloma  multiple  myeloma  new  patients  therapy 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Lymphoma / Leukemia / Myeloma News From Medical News Today

Lymphoma / Leukemia / Myeloma News From Medical News Today



Leukemia is a cancer of the blood cells, usually affecting the white blood cells, which causes these cells to not work properly. There are four main types of leukemia. Lymphoma is a type of cancer that originates in the lymphatic system. There are two mai



Copyright: Copyright 2017 Medical News Today
 



Inhibition of EZH2 might be new therapy of multiple myeloma

Fri, 13 Jan 2017 06:00:00 PST

In a study published in the scientific journal Oncotarget, researchers from Uppsala University show how the protein EZH2 affects the development of multiple myeloma, and that inhibition of EZH2...



Halting lethal childhood leukemia

Tue, 10 Jan 2017 00:00:00 PST

Northwestern Medicine scientists have discovered the genetic driver of a rare and lethal childhood leukemia and identified a targeted molecular therapy that halts the proliferation of leukemic...



Obesity-associated protein could be linked to leukemia development

Fri, 30 Dec 2016 00:00:00 PST

Cancer researchers at the University of Cincinnati (UC) College of Medicine have found an obesity-associated protein's role in leukemia development and drug response which could lead to more...



Tracking down therapy-resistant leukaemia cells

Fri, 16 Dec 2016 02:00:00 PST

Dr. Irmela Jeremias from Helmholtz Zentrum München and her colleagues have succeeded in finding a small population of inactive leukaemia cells that is responsible for relapse of the disease.



Aggressive form of leukaemia linked to defective 'protein factory'

Wed, 14 Dec 2016 06:00:00 PST

20 to 40 percent of the patients with multiple myeloma - a type of leukaemia - have a defect in the ribosome, the protein factory of the cell.



Promising approach for prognosis and treatment in mastocytosis

Wed, 14 Dec 2016 00:00:00 PST

Systemic mastocytosis is a rare, incurable disease that affects approximately one in every 10,000 people.



Scientists use 'molecular-Lego' to take CRISPR gene-editing tool to the next level

Wed, 14 Dec 2016 00:00:00 PST

A team of researchers at Western University is playing with molecular-Lego by adding an engineered enzyme to the revolutionary new gene-editing tool, CRISPR/Cas9.



Fasting could help treat most common childhood leukemia

Tue, 13 Dec 2016 08:00:00 PST

A study reveals that intermittent fasting cleared cancer cells and increased survival in mouse models of acute lymphocytic leukemia.



New oral therapy VENCLYXTO (venetoclax) receives marketing authorisation for patients with difficult-to-treat, chronic lymphocytic leukaemia

Mon, 12 Dec 2016 02:00:00 PST

AbbVie, a global biopharmaceutical company, announced that the European Commission (EC) has authorised VENCLYXTO® (venetoclax) as a first-in-class, oral, once-daily medicine that selectively...



Personalized cancer vaccine is associated with promising outcomes for patients with AML

Fri, 09 Dec 2016 00:00:00 PST

Immunotherapy with personalized vaccine appears to prevent relapse with few side effects in 17-patient trial.



Additions to standard multiple myeloma therapy do not appear to yield additional benefit

Thu, 08 Dec 2016 00:00:00 PST

Largest randomized trial finds second round of chemotherapy or stem cell transplant does not improve progression-free survival.



IKZF1 gene mutations found to increase hereditary risk for ALL in children

Thu, 08 Dec 2016 00:00:00 PST

A late-breaking abstract presented during the 58th American Society of Hematology (ASH) Annual Meeting and Exposition in San Diego identifies inherited genetic mutations in the gene IKZF1 that...



Side effects of leukemia drug can be safely reduced by halving dose

Thu, 08 Dec 2016 00:00:00 PST

Patients with a chronic type of leukaemia could safely reduce the side effects of life-long treatment by cutting their dose in half, according to the results of a University of Liverpool led study...



Advances in multiple myeloma, lymphoma and other hematologic malignancies presented at ASH

Wed, 07 Dec 2016 00:00:00 PST

Researchers from University Hospitals Seidman Cancer Center and Case Western Reserve University School of Medicine presented significant new research findings in multiple myeloma, lymphoma and...



Chemotherapy drug may trigger new egg production in women

Tue, 06 Dec 2016 07:00:00 PST

Small study finds more young eggs in ovaries of women receiving drugs for treating Hodgkin's lymphoma, compared with differently treated or healthy women.



Combination immune therapy shows promise against Hodgkin lymphoma

Tue, 06 Dec 2016 06:00:00 PST

The combination of two new drugs that harness the body's immune system is safe and effective, destroying most cancer cells in 64 percent of patients with recurrent Hodgkin lymphoma, according to...



Nivolumab with chemotherapy improves response, survival in AML study patients

Tue, 06 Dec 2016 06:00:00 PST

The immunotherapy drug nivolumab in combination with standard chemotherapy more than doubled response rates and improved overall survival in patients with acute myeloid leukemia (AML), according to...



In highly lethal type of leukemia, cancer gene predicts treatment response

Fri, 25 Nov 2016 00:00:00 PST

Patients with the most lethal form of acute myeloid leukemia (AML) - based on genetic profiles of their cancers - typically survive for only four to six months after diagnosis, even with aggressive...



Researchers document first reported case of an intermediate stage of lymphoma transformation

Wed, 23 Nov 2016 06:00:00 PST

An uncommon case of blood cancer non-Hodgkin lymphoma developing into classical Hodgkin lymphoma was recently described by American researchers in a case report published in the journal Advances in...



Weight loss may help prevent multiple myeloma

Tue, 22 Nov 2016 00:00:00 PST

New research shows that excess weight increases the risk that a benign blood disorder will progress into multiple myeloma, a cancer of the blood.



Prevalence of Ph-like ALL in adults underscores need for genetic testing, clinical trials

Tue, 22 Nov 2016 00:00:00 PST

A high-risk subtype of acute lymphoblastic leukemia (ALL) first identified in children is highly prevalent in adults with ALL and is associated with a poor outcome, according to an international...



Does Cancer Cause Night Sweats?

Thu, 10 Nov 2016 06:00:00 PST

Learn about excessive sweating in male and female cancer patients and what treatments are available. Also learn about other causes of night sweats.



Potential targeted therapy found for newly identified leukemia subtype with poor outcome

Thu, 10 Nov 2016 00:00:00 PST

An international research team led by St. Jude Children's Research Hospital investigators has uncovered details of a new, high-risk subtype of acute lymphoblastic leukemia (ALL) as well as a...



Genetic hallmarks of acute lymphoblastic leukemia subtype uncovered

Tue, 25 Oct 2016 00:00:00 PST

St. Jude Children's Research Hospital - Washington University Pediatric Cancer Genome Project team identifies genetic changes underlying a type of B-precursor acute lymphoblastic leukemiaAn...



New drug combination shows promise in tackling leukaemia treatment resistance

Tue, 18 Oct 2016 06:00:00 PST

Early testing of a new drug combination that attacks the most common form of leukaemia on multiple fronts has shown great promise in targeting cancer cells.